Member Info for Kevinl1977

LPD was 11th November.

Any significant findings from the deep dive, whether positive or negative will need to be reported, via an RNS, immediately. This will be prior to the conference.
Common sense tells you, positive findings will have a positive impact on the SP, negative and it will nosedive.
Financials will be reported, as Tommy stated, towards the end of next month.

SNG
We had a lengthy discussion on this a while ago.
Vaccinations do affect menstruation cycles. I raised it at the time as my missus was experiencing the same symptoms you stated.
Severity of illness was bizarre in our household. My missus had a severe chest infection, despite her immunity normally being rock solid from working in hospitals, whereas I had very mild symptoms. We were both fully vaccinated and boostered.

SNG
I have to agree on the vaccines narrative, as it’s a discussion that I’ve been involved in more and more.
Also, yes the American market was always the target; fingers crossed that we do better this time.
ATB

Mr Costs
Yes, you are being negative with that comment.
How could they have set up anything before the results of the P3?
RM stated that he was in discussions, networking, etc.
This time, the P3 has been completed, so are we hoping for a different outcome?
ATB

Good post Trinity.
Should the deep dive and A2 data unearth any gems you need to factor in Polygon too.
What will their strategy be, should this happen?
Also, only my opinion, but I don’t think the Synairgen team have enough clout or expertise to bring this to market without a JV.
ATB

It’s the timelines that the market doesn’t like, imo.
If you know there will be important news in 5 weeks, why would you invest now unless you are planning to build a position.

How do you suggest they do that?
There can’t be any sales as we don’t have approval for the drug to be used, yet.
There is no volume as the recent RM video tells a timeline of mid May.
Unless you are building a position, I would imagine that most investors will get involved just prior to the conference and unblinding of the deep dive data.

Many thanks to all contributors.
Let’s hope that the Synairgen team are as well researched.
GLA

It’s only when you begin to look at this that you can understand many people have a lot to answer for in the way this trial has been administered.
Surely, this must be common knowledge and so should have been fed down the clinician line?
Whether this is a Synairgen team, hospitals running the trials, or a combination of both blame?
Regardless, 87% received SOC in the form of steroids!
Add 30% improvements to our 36 and we get a very impressive 66%.
Surely, some interesting narratives to emerge from the Deep dive?

Andy
Sorry for the delay, been hard at it all day.
It’s an interesting question you pose.
Pre-readout I had my doubts, but was trying to be positive, believing that he knew what he was doing.
I, like many, were overwhelmed by the evidence that was lined up mainly from investors. My concerns were generally from a lack of communication as I believe it is a CEOs role to keep lines of communication open.
I certainly can’t judge him on the last 17 years as I’ve only been invested here for a couple of years and it would be highly unfair to give an opinion.
I can’t remember anyone on here discussing SOC, pre readout, and there have been some highly intelligent posters; did anyone consider this?
I’m not a biotech specialist, so can’t comment on SOC, I only listen and try to come to a sensible judgement.
I feel your pain, as it’s disappointing.
But, at this point, it’s no good constantly moaning. He has failed to inspire; will he learn and recover?
We will see in the next 4-6 weeks for sure.
ATB

I’m watching from afar, where possible, but your postings are ridiculous.
Are you a Biotech expert?
No, so why are you constantly giving the same tiring opinion on here?
Are you a CEO?
No, you are a level headed, responsible and calm individual that works in the City. You said that you can recoup your losses quite easily, because of your job, so why the incessant and obsessive rants?
We are all frustrated, none more so than me, but trying to get a response from other investors on here will not do anything to the SP or the companies strategy.
We invested in the drug and believed in the Company.
Have some belief and dare I say it, even more patience for just 6 more weeks and let’s hope the deep dive and A2 brings some gems.
If not, then we have to face the facts that we made a mistake for investing in Synairgen.
I do feel your pain, but this is not the way forward imo.
ATB LTHs.

Change your broker!

Long term holders; follow the money.
They got it wrong the first time, due to unforeseen circumstances, like we all did.
4-6 weeks time the path will hopefully be clearer.
Patience and GLA.

Come on folks, wake up!!
If there is to be any market sensitive news in this proposed interview, then their will need to be an RNS first.
If not, it will just be a repeat of what we already now.
GLA

Many thanks BG.

Doc
I agree with your last paragraph.
Tommy is also doing sterling research, as you quite rightly say.
Pre-Sprinter readout, as you are aware, we had so many impressive posters and researchers on this board. The evidence for being invested was pretty overwhelming. Those contributors are still invested here, but watching from afar.
In my opinion, it now doesn’t matter what evidence is stacked up on this board, the SP will take its own course. The only action that will make the SP fly North, will have to come from the Synairgen team. It will reinforce that we still have some hope, but until we get news from the SYN team, plateau is the word!
Trading this share, is now virtually impossible imo due to the spreads set by MM and the minimal movements of the SP.
So, it’s sit on your hands time, yet again, and live in hope due to the lack of comms that the team are lifting the gems from the stone.
GLA

We have thankyou.
Not sure they give out antibiotics for a cold??
ATB

Mmmm
One thing for sure is the volume is low!

You can never be sure that sells are not buys and vice-versa. Check the price at the time v bid and ask.
One thing for sure is the volume is low!